Seramune I.V.
This treatment applies to the following species:equine IgG
dose: administer 250ml intravenously in no less than 30 minutes; repeat as clinical conditions indicate, within first 120 hours of life
● store refrigerated at 2 - 8° C/35 - 46° F; do not freeze
● once opened, use entire contents as directed above
to facilitate use, the following measures are suggested:
● dilute product into 1 - 2 liters of lactated ringers
● warm solution to body temperature
● premedicate with an anti-inflammatory and / or sedative in accordance with current practice standards in neonatal foals
● administer slowly for first 3 - 5 minutes
bottle contains one dose of 250ml
for use by or under the direction of a veterinarian
Seramune I.V. Indications
for the treatment of failure of passive transfer in neonatal foals
do not mix with other products, except as specified on the label
in case of human exposure, contact a physician
with any serum product, adverse reactions may occur; in case of reactions, stop treatment and administer epinephrine
use of equine serum and plasma products has been associated with hepatitis (Theiler’s Disease)
VLN/PCN 328/3607.00
250mL
sera, inc., po box 15866, shawnee mission, kansas 66285-5866 usa
913-541-1307
CPN: 1498000.2
P.O. BOX 15866, SHAWNEE MISSION, KS, 66285-5866
Telephone: | 913-541-1307 | |
Customer Service: | adamforeman@seramune.com | |
Order Desk: | adamforeman@seramune.com | |
Technical Service: | nicolegreen@seramune.com | |
Website: | www.seramune.com | |
Email: | info@seramune.com |
THIS SERVICE AND DATA ARE PROVIDED "AS IS". DVMetrics assumes no liability, and each user assumes full risk, responsibility, and liability, related to its use of the DVMetrics service and data. See the Terms of Use for further details. |
Copyright © 2024 Animalytix LLC. Updated: 2024-08-26